Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 3271 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed637    
    Printed30    
    Emailed0    
    PDF Downloaded107    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 2003  |  Volume : 45  |  Issue : 1  |  Page : 30-35

Risk Factors in Neuroleptic Malignant Syndrome


1 Reader, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
2 Resident. Department of Psychiatry, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
3 Resident, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
4 Reader in clinical Psychology, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab, India

Correspondence Address:
Vinay Gupta
Reader, Department of Psychiatry, Dayanand Medical College & Hospital, Ludhiana, Punjab
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21206810

Rights and PermissionsRights and Permissions

Neuroleptic malignant syndrome (NMS) is an uncommon but potentially serious idiosyncratic response to neuroleptic antipsychotics. It usually affects young males, but the risk has been seen to increase with certain factors including the administration practices of antipsychotic neuroleptics in these individuals. Even though no predictors for NMS are yet known, this article highlights the findings on certain risk factors as seen from a series of fifteen patients who developed NMS. Cautious use of neuroleptics in those at risk, early recognition and institution of immediate management is important.



[PDF]*

        

Print this article         Email this article